How California Institute for Regenerative Medicine research programs support science and regulatory policy.
California Institute for Regenerative Medicine, San Francisco, California, USA glomax@cirm.ca.gov.
Geoffrey P
GP
Lomax
California Institute for Regenerative Medicine, San Francisco, California, USA.
Natalie D
ND
DeWitt
California Institute for Regenerative Medicine, San Francisco, California, USA.
Maria T
MT
Millan
California Institute for Regenerative Medicine, San Francisco, California, USA.
Ellen G
EG
Feigal
D000047:Academies and Institutes / Q000331:legislation & jurisprudence / Q000458:organization & administration; D000818:Animals; D002140:California; D003299:Cooperative Behavior; D006077:Government Agencies / Q000331:legislation & jurisprudence / Q000458:organization & administration; D006801:Humans; D033183:Interdisciplinary Communication; D017146:Models, Organizational; D009937:Organizational Objectives; D010506:Periodicals as Topic; D044968:Regenerative Medicine / Q000331:legislation & jurisprudence / Q000458:organization & administration; D013219:State Government; D057905:Stem Cell Research / Q000331:legislation & jurisprudence; D057170:Translational Research, Biomedical / Q000331:legislation & jurisprudence / Q000458:organization & administration
Clinical trials; Drug target; Genomics; Induced pluripotent stem cells